SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-155290
Filing Date
2019-05-23
Accepted
2019-05-23 15:59:03
Documents
2
Period of Report
2019-05-17
Items
Item 1.03: Bankruptcy or Receivership
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d753779d8k.htm 8-K 25658
2 EX-2.1 d753779dex21.htm EX-2.1 221423
  Complete submission text file 0001193125-19-155290.txt   248212
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 19850002
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences